Skip to content

Homoeopathy in Alopecia Areata

ROLE OF INDIVIDUALIZED HOMOEOPATHIC MEDICINES IN TREATMENT OF ALOPECIA AREATA IN ADULTS USING KENTS REPERTORY A PRE POST INTERVENTIONAL STUDY - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/077493
Enrollment
40
Registered
2024-11-29
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L639- Alopecia areata, unspecified

Interventions

Intervention1: Individualized Homoeopathic Medicine: Medicines will be procured from GMP certified company and will be dispensed from the Dispensary of MBHMC&H. All the medicines will be administered

Sponsors

Mahesh Bhattacharyya Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosed cases of Alopecia areata (Using Symptoms mainly) The diagnosis of alopecia areata is usually made on clinical grounds and in most cases, further tests are not needed. Affected individuals report hair loss and the abrupt appearance of a hairless area which is circular having standard skin color. Presence of Exclamation mark hair at the periphery of the lesion is pathognomonic. 2. Adult population Aged between 18years to 65 years of all sexes. 3. Patients using topical agents for Alopecia will be included after a washout period of one month. 4. Patients giving written consent to participate.

Exclusion criteria

Exclusion criteria: 1. Alopecia universalis. 2. Alopecia Totalis. 3. Ophiasis and Sisaipho. 4. Individuals diagnosed with unstable psychiatric illness. 5. Any uncontrolled systemic diseases. 6. Substance abuse and/or dependance. 7. Pregnant and Lactating women. 8. Those treated with any kind of local steroidal injection. 9. Undergoing homoeopathic treatment for any chronic diseases within last 1 month.

Design outcomes

Primary

MeasureTime frame
The Severity of Alopecia Tool (SALT)Timepoint: will be assessed at Baseline & after 6 months of treatment.

Secondary

MeasureTime frame
Alopecia Areata Quality of Life Questionnaire (AA-QLI)Timepoint: will be assessed at Baseline & after 6 months of treatment.;Modified Naranjo Criteria for Homoeopathy(MONARCH)Timepoint: will be assessed after 6 months of treatment.

Countries

India

Contacts

Public ContactDr. Anwesha Mondal

Mahesh Bhattacharyya Homoeopathic Medical College and Hospital

dr.samit77@gmail.com9875371414

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026